Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.5451 -0.0559 (-9.30%)
Streaming Delayed Price Updated: 3:21 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q3 2025 Results Amid Restructuring Efforts ↗
Harvard Bioscience (HBIO) posted mixed Q3 2025 results, beating on revenue but missing on EPS. Despite the miss, the stock surged as investors focus on strong order growth and a positive restructuring... 
Via Chartmill
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
Check out the stocks that are attracting the most attention and driving market activity. ↗
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today. 
Via Chartmill
News headline image
Here are the top movers in Thursday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
- Strategic expansion with trusted partner enhances customer reach 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
Veteran life sciences industry financing leader appointed as new Board member 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q2 2025 Earnings Amid Revenue Miss and Improved Cash Flow ↗
Harvard Bioscience (HBIO) reported mixed Q2 2025 results, missing revenue estimates but matching EPS. Improved cash flow and cost control offset weak sales, with stock up 18.7% pre-earnings. 
Via Chartmill
News headline image
Harvard Bioscience Tops Q2 Revenue Views ↗
Via The Motley Fool
News headline image
Harvard Bioscience Announces Second Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Which stocks are moving on Monday? ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.